iNext is a pitching competition designed to spark transformational “moon-shot” ideas. Sanofi invites innovative Startups and Academic Labs from both North America and Europe to submit groundbreaking proposals.
These proposals should focus on Next-Gen approaches to counter aging-related cellular and tissue dysfunction, or on paradigm-shifting strategies for the targeted delivery of large molecules.
A groundbreaking initiative designed to bridge the gap between innovation and patient care. This pitching competition aims to identify and incubate breakthrough ideas that push the boundaries of traditional R&D and venture investment frameworks. Selected “Moonshot” ideas will receive up to USD $500,000 per project (inclusive of all costs) to fund an 18-months journey of groundbreaking research, supported by Sanofi’s R&D expertise.
Sanofi iNext targets high-risk cutting edge ideas that currently falls outside the scope of existing funding mechanisms that support early stage innovation. Together, we’re shaping the future of healthcare, by empowering bold ideas and fostering transformative breakthroughs.
Next-Gen approaches to counter aging related cellular and tissue dysfunction. Paradigm shifting strategies for targeted delivery of large molecules including proteins (antigenic and therapeutic) and genetic material across biological barriers (skin, mucosa, BBB, intracellular/intranuclear)
Awards:- Up to $500,000 per project – 3 projects to be funded (for Vaccine and Therapeutic approaches) – 18 months of project duration.
Deadline:- 31-01-2026
